A Randomized, Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Ceftazidime-Avibactam in Healthy Chinese Subjects

The antibiotic resistance crisis: part 1: causes and threats.

C Lee Ventola · PubMed · 2015 · 4.7K citations

Life Sciences, Infectious Diseases, Pharmacotherapy +14

Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment

Sibhghatulla Shaikh, Jamale Fatima, Shazi Shakil et al. · Saudi Journal of Biological Sciences · 2014 · 758 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

The Role of Ethnicity in Variability in Response to Drugs: Focus on Clinical Pharmacology Studies

SU Yasuda, L Zhang, Huang Sm · Clinical Pharmacology & Therapeutics · 2008 · 393 citations

Medicine, Pharmacokinetics, Pharmacology +15

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

John E. Mazuski, Leanne B. Gasink, J. Armstrong et al. · Clinical Infectious Diseases · 2016 · 385 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial

Christopher Lucasti, Irinel Popescu, M Ramesh et al. · Journal of Antimicrobial Chemotherapy · 2013 · 234 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12